Literature DB >> 1268862

Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia.

G J Hill, T E Shine, H Z Hill, C Miller.   

Abstract

Parenteral amygdalin was found to be ineffective in C57BL/6 mice with B16 melanoma and in AKR mice with BW5147 lymphatic leukemia, in doses ranging from 50 to 5000 mg/kg.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1268862

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Laetrile.

Authors:  J P Lewis
Journal:  West J Med       Date:  1977-07

2.  Pharmacology of amygdalin (laetrile) in cancer patients.

Authors:  M M Ames; T P Moyer; J S Kovach; C G Moertel; J Rubin
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia.

Authors:  M P Chitnis; M K Adwankar; A J Amonkar
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Amygdalin (Laetrile) and prunasin beta-glucosidases: distribution in germ-free rat and in human tumor tissue.

Authors:  J Newmark; R O Brady; P M Grimley; A E Gal; S G Waller; J R Thistlethwaite
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.